@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system> a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "eclaire-study-phase-source-code-system"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">jarde-early<a name=\"eclaire-study-phase-source-code-system-jarde-early\"> </a></td><td>Jardé phase précoce</td></tr><tr><td style=\"white-space:nowrap\">phase-I-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-first-admin\"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-bioequivalence\"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-other<a name=\"eclaire-study-phase-source-code-system-phase-I-other\"> </a></td><td>Human Pharmacology (Phase I) -  Other</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-admin<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-admin\"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-first-bioequivalence<a name=\"eclaire-study-phase-source-code-system-phase-I-II-first-bioequivalence\"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style=\"white-space:nowrap\">phase-I-II-other<a name=\"eclaire-study-phase-source-code-system-phase-I-II-other\"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style=\"white-space:nowrap\">phase-II<a name=\"eclaire-study-phase-source-code-system-phase-II\"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style=\"white-space:nowrap\">phase-II-III<a name=\"eclaire-study-phase-source-code-system-phase-II-III\"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style=\"white-space:nowrap\">phase-III<a name=\"eclaire-study-phase-source-code-system-phase-III\"> </a></td><td>Therapeutic confirmatory  (Phase III)</td></tr><tr><td style=\"white-space:nowrap\">phase-IV<a name=\"eclaire-study-phase-source-code-system-phase-IV\"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style=\"white-space:nowrap\">phase-III-IV<a name=\"eclaire-study-phase-source-code-system-phase-III-IV\"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>"
  ] ; # 
  fhir:url [ fhir:v "https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.3.0"] ; # 
  fhir:name [ fhir:v "EclaireStudyPhaseSourceCS"] ; # 
  fhir:title [ fhir:v "Définition des phase de l'essai utilisés dans la base de données ECLAIRE"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:date [ fhir:v "2024-02-26T13:32:37+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "ANS"] ; # 
  fhir:contact ( [
     fhir:name [ fhir:v "ANS" ] ;
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "https://esante.gouv.fr" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Définition des phases de l'essai utilisées dans la base de données ECLAIRE"] ; # 
  fhir:jurisdiction ( [
     fhir:coding ( [
       fhir:system [ fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "FR" ] ;
       fhir:display [ fhir:v "FRANCE" ]
     ] )
  ] ) ; # 
  fhir:caseSensitive [ fhir:v "true"^^xsd:boolean] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "12"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
     fhir:code [ fhir:v "jarde-early" ] ;
     fhir:display [ fhir:v "Jardé phase précoce" ]
  ] [
     fhir:code [ fhir:v "phase-I-first-admin" ] ;
     fhir:display [ fhir:v "Human Pharmacology (Phase I) - First administration to humans" ]
  ] [
     fhir:code [ fhir:v "phase-I-bioequivalence" ] ;
     fhir:display [ fhir:v "Human Pharmacology (Phase I) - Bioequivalence Study" ]
  ] [
     fhir:code [ fhir:v "phase-I-other" ] ;
     fhir:display [ fhir:v "Human Pharmacology (Phase I) -  Other" ]
  ] [
     fhir:code [ fhir:v "phase-I-II-first-admin" ] ;
     fhir:display [ fhir:v "Phase I and Phase II (Integrated) - First administration to humans" ]
  ] [
     fhir:code [ fhir:v "phase-I-II-first-bioequivalence" ] ;
     fhir:display [ fhir:v "Phase I and Phase II (Integrated) - Bioequivalence Study" ]
  ] [
     fhir:code [ fhir:v "phase-I-II-other" ] ;
     fhir:display [ fhir:v "Phase I and Phase II (Integrated) - Other" ]
  ] [
     fhir:code [ fhir:v "phase-II" ] ;
     fhir:display [ fhir:v "Therapeutic exploratory (Phase II)" ]
  ] [
     fhir:code [ fhir:v "phase-II-III" ] ;
     fhir:display [ fhir:v "Phase II and Phase III (Integrated)" ]
  ] [
     fhir:code [ fhir:v "phase-III" ] ;
     fhir:display [ fhir:v "Therapeutic confirmatory  (Phase III)" ]
  ] [
     fhir:code [ fhir:v "phase-IV" ] ;
     fhir:display [ fhir:v "Therapeutic use (Phase IV)" ]
  ] [
     fhir:code [ fhir:v "phase-III-IV" ] ;
     fhir:display [ fhir:v "Phase III and phase IV (Integrated)" ]
  ] ) . # 

# -------------------------------------------------------------------------------------

